When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KYKOF - FDA OK's Kyowa Kirin's istradefylline for Parkinson's
Kyowa Hakko Kogyo
The FDA approves Kyowa Kirin's (OTCPK:KYKOF) Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa for adults with Parkinson's disease (PD) who are experiencing "off" episodes.
More news on: Kyowa Kirin Co., Ltd., Healthcare stocks news,